The evolving role of PARP inhibitors in advanced ovarian cancer

Authors: Levva Sofia, Skolariki Aglaia, Sogka Eleni, Bokas Alexandros, Assi Avraam, Pispirigou Marianna K., Koliou Panagiotis

Source: Forum of Clinical Oncology, Vol 12, Iss 1, Pp 82-104 (2021)

Subject Terms: ovarian cancer, parp inhibitors, brca mutation, maintenance treatment, resistance mechanisms, homologous recombination deficiency, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1792-362X

Access URL: https://doaj.org/article/89451a0136684152b7849f531e5429c8

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors.

Authors: Stavropoulou De Lorenzo, Sotiria, Andravizou, Athina, Alexopoulos, Harry, Michailidou, Iliana, Bokas, Alexandros, Kesidou, Evangelia, Boziki, Marina-Kleopatra, Parissis, Dimitrios, Bakirtzis, Christos, Grigoriadis, Nikolaos

Source: Biomedicines; Jun2024, Vol. 12 Issue 6, p1319, 22p

Subject Terms: DRUG side effects, IMMUNE checkpoint inhibitors, PHYSICIANS, MEDICAL personnel, SYMPTOMS

Thromboprophylaxis in active cancer patients: Is it a controversial clinical issue or not? Preliminary results of ACT4CAT study.

Authors: Tsoukalas, Nikolaos, Christopoulou, Athina, Papandreou, Christos N., Koumarianou, Anna, Athanasiadis, Ilias, Peroukidis, Stavros, Samelis, Georgios, Psyrri, Amanda, Kapodistrias, Nikolaos, Nikolakopoulos, Achilleas, Andreadis, Charalampos, Ardavanis, Alexandros, Samantas, Epaminondas, Bokas, Alexandros, Vassilios, Barbounis, Kentepozidis, Nikolaos K., Mavroudis, Dimitrios, Athanasiadis, Athanasios, Papakotoulas, Pavlos, Boukovinas, Ioannis

Source: Journal of clinical oncology. 39(15 suppl):e18803-e18803

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173214254.0x000001&indx=1&recIds=ETOCvdc_100173214254.0x000001

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer.

Authors: Sarantis, Panagiotis¹ (AUTHOR) panayotissarantis@gmail.com, Bokas, Alexandros^1,2 (AUTHOR) alexanderbokas@outlook.com, Papadimitropoulou, Adriana³ (AUTHOR) adapapadim@gmail.com, Koustas, Evangelos¹ (AUTHOR) vang.koustas@gmail.com, Theocharis, Stamatios⁴ (AUTHOR) statheocharis@yahoo.com, Papakotoulas, Pavlos² (AUTHOR), Schizas, Dimitrios⁵ (AUTHOR) schizasad@gmail.com, Papalampros, Alexandros⁵ (AUTHOR) a_papalampros@hotmail.com, Felekouras, Evangelos⁵ (AUTHOR) evangelosfelek@hotmail.com, Papavassiliou, Athanasios G.¹ (AUTHOR) papavas@med.uoa.gr, Karamouzis, Michalis V.¹ (AUTHOR) papavas@med.uoa.gr

Source: International Journal of Molecular Sciences. Jul2021, Vol. 22 Issue 13, p7053-7053. 1p.

Subject Terms: *PANCREATIC cancer, *PACLITAXEL, *THERAPEUTICS, *TREATMENT effectiveness, *LABORATORY mice, *CANCER chemotherapy

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas.

Authors: Bokas, Alexandros^1,2 (AUTHOR) alexanderbokas@outlook.com, Papakotoulas, Pavlos^1,2 (AUTHOR) papakotoulas@gmail.com, Sarantis, Panagiotis² (AUTHOR), Papadimitropoulou, Adriana³ (AUTHOR) adapapadim@gmail.com, Papavassiliou, Athanasios G² (AUTHOR), Karamouzis, Michalis V^2,4 (AUTHOR) mkaramouz@med.uoa.gr

Source: Cancers. Feb2020, Vol. 12 Issue 2, p432. 1p.

Subject Terms: *ADENOCARCINOMA, *ANTINEOPLASTIC agents, *IMMUNOTHERAPY, *PANCREATIC tumors, *THROMBOEMBOLISM, *TREATMENT effectiveness, *ENOXAPARIN, *PHARMACODYNAMICS, THROMBOEMBOLISM prevention

Real world data for venous thromboembolisms (VTEs) in patients with active cancer: Thromboprophylaxis pooled analysis from GMaT and ACT4CAT studies.

Authors: Tsoukalas, Nikolaos, Christopoulou, Athina, Timotheadou, Eleni, Koumarianou, Anna, Ardavanis, Alexandros, Athanasiadis, Ilias, Demiri, Stamatina G, Bokas, Alexandros, Samelis, Georgios, Peroukidis, Stavros, Papatsibas, George, Andreadis, Charalampos, Nikolakopoulos, Achilleas, Psyrri, Amanda, Kapodistrias, Nikolaos, Papakostas, Pavlos, Aravantinos, Gerasimos, Athanasiadis, Athanasios, Papakotoulas, Pavlos, Boukovinas, Ioannis

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p6637-6637, 1p

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.

Authors: Christopoulou, Athina, Ardavanis, Alexandros, Papandreou, Christos, Koumakis, Georgios, Papatsimpas, Georgios, Papakotoulas, Pavlos, Tsoukalas, Nikolaos, Andreadis, Charalambos, Samelis, Georgios, Papakostas, Pavlos, Aravantinos, Gerasimos, Ziras, Nikolaos, Souggleri, Maria, Kalofonos, Charalambos, Samantas, Epameinondas, Makrantonakis, Paris, Pentheroudakis, Georgios, Athanasiadis, Athanasios, Stergiou, Helen, Bokas, Alexandros

Source: Oncology Letters; Apr2022, Vol. 23 Issue 4, pN.PAG-N.PAG, 1p

Subject Terms: THROMBOEMBOLISM, BODY mass index, PANCREATIC tumors, PULMONARY embolism, PREVENTIVE medicine

A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The 'LUNGFUL' Study

Authors: Mountzios, Giannis, Koumarianou, Anna, Bokas, Alexandros, Mavroudis, Dimitrios, Samantas, Epaminondas, Fergadis, Evangelos Georgios, Linardou, Helena, Katsaounis, Panagiotis, Athanasiadis, Elias, Karamouzis, Michalis V., Pentheroudakis, George, Lampaki, Sofia, Froudarakis, Marios E., Perdikouri, Eleni-Isidora A., Somarakis, Alvertos, Papageorgiou, Foteini, Paparepa, Zoe, Nikolaou, Aristeidis, Syrigos, Konstantinos N.

Source: Cancers; Jul2021, Vol. 13 Issue 13, p3172-3172, 1p

Subject Terms: DISEASE progression, LUNG cancer, GENETIC mutation, SCIENTIFIC observation, BIOPSY, EPIDERMAL growth factor receptors, BLOOD plasma, METASTASIS, PROTEIN-tyrosine kinase inhibitors, TISSUES, DESCRIPTIVE statistics, MOLECULAR epidemiology, PHYSICIANS, CYTOLOGY, BODY fluid examination, LONGITUDINAL method

Geographic Terms: GREECE

The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study.

Authors: Karamouzis, Michalis V., Athanasiadis, Ilias, Samelis, Georgios, Vallilas, Christos, Bokas, Alexandros, Nikolaidi, Adamantia, Dimitriadou, Areti, Sarantis, Panagiotis, Pistamaltzian, Nikolaos, Schizas, Dimitrios, Papalampros, Alexandros, Felekouras, Evangelos, Dimitroulis, Dimitrios, Antoniou, Eustathios, Sotiropoulos, Georgios, Papakotoulas, Pavlos

Source: Cancers; Jun2021, Vol. 13 Issue 12, p2884, 1p

Subject Terms: THROMBOSIS prevention, PANCREATIC tumors, SURVIVAL, DRUG efficacy, COMBINATION drug therapy, SCIENTIFIC observation, CANCER chemotherapy, ANTICOAGULANTS, RETROSPECTIVE studies, TREATMENT effectiveness, PATIENT safety, EVALUATION

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.